Skip to main content
icon for 美国7月31日之前的环孢子虫病病例?

美国7月31日之前的环孢子虫病病例?

icon for 美国7月31日之前的环孢子虫病病例?

美国7月31日之前的环孢子虫病病例?

最新
2026-07-31
Polymarket

$763 交易量

Polymarket

1800+

$102 交易量

60%

2000+

$47 交易量

64%

2500以上

$652 交易量

83%

3000+

$117 交易量

32%

5000+

$42 交易量

20%

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.As of mid-July 2026, CDC surveillance shows the typical seasonal rise in cyclosporiasis cases driven by foodborne transmission of Cyclospora cayetanensis oocysts in contaminated fresh produce such as berries and leafy greens. Confirmed case counts remain consistent with historical summer patterns rather than indicating a large multistate outbreak, supporting trader focus on whether totals will exceed baseline thresholds by July 31. Key variables include import volumes, produce sourcing changes, and any new clusters identified through notifiable disease reporting. CDC's ongoing weekly or monthly updates on laboratory-confirmed cases will provide the next authoritative data releases that could shift market-implied odds.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
交易量
$763
结束日期
2026-07-31
市场开放时间
Jul 14, 2026, 9:55 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.As of mid-July 2026, CDC surveillance shows the typical seasonal rise in cyclosporiasis cases driven by foodborne transmission of Cyclospora cayetanensis oocysts in contaminated fresh produce such as berries and leafy greens. Confirmed case counts remain consistent with historical summer patterns rather than indicating a large multistate outbreak, supporting trader focus on whether totals will exceed baseline thresholds by July 31. Key variables include import volumes, produce sourcing changes, and any new clusters identified through notifiable disease reporting. CDC's ongoing weekly or monthly updates on laboratory-confirmed cases will provide the next authoritative data releases that could shift market-implied odds.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
交易量
$763
结束日期
2026-07-31
市场开放时间
Jul 14, 2026, 9:55 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.

警惕外部链接哦。

常见问题

"美国7月31日之前的环孢子虫病病例?"是 Polymarket 上一个拥有 5 个可能结果的预测市场,交易者根据自己的判断买卖份额。当前领先结果为"2500以上",概率为 83%,其次是"2000+",概率为 64%。价格反映社区的实时概率。例如,价格为 83¢ 的份额意味着市场集体认为该结果的概率为 83%。这些赔率会随着交易者的反应而不断变化。正确结果的份额在市场结算时可兑换为每份 $1。

"美国7月31日之前的环孢子虫病病例?"是 Polymarket 上新创建的市场,于Jul 14, 2026上线。作为一个新市场,这是你率先设定赔率并建立初始价格信号的机会。你也可以将本页加入书签,以便跟踪交易量和活动。

要在"美国7月31日之前的环孢子虫病病例?"上交易,浏览本页上列出的 5 个可用结果。每个结果显示一个代表市场隐含概率的当前价格。要建仓,选择你认为最可能的结果,选择"是"支持或"否"反对,输入金额并点击"交易"。如果你选择的结果在市场结算时正确,你的"是"份额每份支付 $1。如果不正确,支付 $0。你也可以在结算前随时卖出份额。

"美国7月31日之前的环孢子虫病病例?"的当前领先者是"2500以上",概率为 83%,意味着市场对该结果的概率评估为 83%。紧随其后的结果是"2000+",概率为 64%。这些赔率随着交易者买卖份额而实时更新。请经常回来查看或将本页加入书签。

"美国7月31日之前的环孢子虫病病例?"的结算规则明确定义了每个结果被宣布为获胜者所需满足的条件——包括用于确定结果的官方数据来源。你可以在本页评论上方的"规则"部分查看完整的结算标准。我们建议在交易前仔细阅读规则,因为它们规定了精确的条件、特殊情况和数据来源。